SCHEMBL1443006

SCHEMBL1443006

CC(C)NC(=O)c1ccc(-c2ccc3ncc(N4CCCCC4)nc3c2)cc1.O=C(NC1CC1)c1ccc(-c2ccc3ncc(N4CCCCC4)nc3c2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CKS1B P61024 1/20 0.45
▸ SKP1 P63208 1/20 0.45
▸ SKP2 Q13309 1/20 0.45
▸ HPGDS O60760 4/20 0.44
▸ TTK P33981 2/20 0.44
▸ STK17A Q9UEE5 2/20 0.44
▸ NEK3 P51956 1/20 0.44
▸ LIMK1 P53667 1/20 0.44
▸ NEK5 Q6P3R8 1/20 0.44
▸ MYLK4 Q86YV6 1/20 0.44
▸ ROCK2 O75116 3/20 0.43
▸ ROCK1 Q13464 1/20 0.43
▸ BMPR1B O00238 1/20 0.43
▸ BMPR1A P36894 1/20 0.43
▸ TGFBR1 P36897 1/20 0.43
▸ ACVRL1 P37023 1/20 0.43
▸ ACVR1 Q04771 1/20 0.43
▸ BRAF P15056 1/20 0.42
▸ ATM Q13315 2/20 0.41
▸ SMYD3 Q9H7B4 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12811797 0.93 CKS1B (0.50) CKS1BSKP1SKP2HPGDSSTK17A
SCHEMBL12811789 0.92 STK17A (0.49) STK17ANEK3LIMK1NEK5MYLK4
SCHEMBL1443346 0.84 MYLK4 (0.52) STK17ANEK3LIMK1NEK5MYLK4
SCHEMBL1443590 0.84 MAPK14 (0.50) CKS1BSKP1SKP2HPGDSBMPR1B
SCHEMBL12812434 0.84 STK17A (0.51) STK17ANEK3LIMK1NEK5MYLK4
SCHEMBL1442549 0.82 PIK3CA (0.47) PIK3CA
SCHEMBL12812416 0.80 PIK3CA (0.47) CKS1BSKP1SKP2HPGDSTTK
SCHEMBL1442311 0.80 BMPR1B (0.47) CKS1BSKP1SKP2HPGDSBMPR1B
SCHEMBL12812066 0.80 ATM (0.46) ATMPIK3CA
SCHEMBL1442107 0.79 PIK3CA (0.47) STK17AATMPRKDCPIK3CA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2473498-A1 SUBSTITUTED AMINOQUINOXALINES AS TYROSINE THREONINE KINASE INHIBITORS Bayer Pharma Aktiengesellschaft (DE) 2012-07-11 — — EP claimed
WO-2011026579-A1 SUBSTITUTED AMINOQUINOXALINES AS TYROSINE THREONINE KINASE INHIBITORS BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2011-03-10 — — WO claimed
Send feedback